trial

Acceptance and Commitment Therapy (ACT) in Early Psychosis Patients

NCTId NCT05210816
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 40 (actual)
Sponsored by Saglik Bilimleri Universitesi
Primary completion 2022-06-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
40 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2022-01-01
Primary completion
2022-06-30
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Acceptance and Commitment Therapy

Sponsors

Saglik Bilimleri UniversitesiLead Sponsor

Investigators

1
Duygu ÖZER, MsNPrincipal Investigator

Sites

1 total
Istanbul, Turkey (Türkiye)

Facts & assertions

4 sourced
Enrollment
40
Phase
NA
Primary Completion Date
2022-06-30
Status
COMPLETED
relationships
The graph out of here
drug
Acceptance and Commitment Therapy
drug
lead_sponsor
Saglik Bilimleri Universitesi
company
indication
Psychiatric Nursing
indication
Psychotic Disorders
indication
Acceptance and Commitment Therapy
indication
investigator
Duygu ÖZER, MsN
person